[Correlation between Serum G-CSF Level and Immune Function in Children with Aplastic Anemia]

Rong Ren1, Jing Han2

  • 1Department of Pediatric Hematology, Tangshan Maternal & Child Health Hospital, Tangshan 063000, Hebei Province, China,E-mail: eavorforever@163.com.

Insights

Children with aplastic anemia (AA) treated with immunosuppressive therapy (IST) face a higher risk of immune dysfunction. Low serum granulocyte colony-stimulating factor (G-CSF) levels are linked to this dysfunction and can help predict its occurrence.

Area of Science:

  • Pediatric Hematology
  • Immunology
  • Oncology

Background:

  • Aplastic anemia (AA) is a rare but serious condition.
  • Immunosuppressive therapy (IST) is a common treatment for AA.
  • Immune dysfunction can be a complication of IST.

Purpose of the Study:

  • To investigate the incidence of immune dysfunction in children with AA post-IST.
  • To identify factors contributing to immune dysfunction in these patients.
  • To analyze the correlation between granulocyte colony-stimulating factor (G-CSF) levels and immune dysfunction.

Main Methods:

  • 34 children with AA received IST for 6 months.
  • Patients were divided into groups based on immune dysfunction occurrence post-treatment.
  • Serum G-CSF and Interferon-gamma (IFN-γ) levels were measured and compared.
  • Regression analysis and ROC curves were used to assess G-CSF's predictive value.

Main Results:

  • 35.29% of children developed immune dysfunction after IST.
  • The immune dysfunction group had higher IFN-γ and lower G-CSF levels.
  • Low G-CSF expression was identified as a significant risk factor for immune dysfunction (OR>1, P<0.05).
  • Serum G-CSF demonstrated good predictive value for immune dysfunction (AUC=0.843).

Conclusions:

  • Children with AA are at increased risk of immune dysfunction following IST.
  • Low serum G-CSF expression is associated with post-IST immune dysfunction in pediatric AA.
  • Monitoring serum G-CSF levels may aid in predicting and managing immune dysfunction in these patients.
Abstract